6 ..................................................................................................................................................................................

8 ...............................................................................................................................................................

:
:
11 ........................................................................................................................................................................................
13 ........................................................................................................................................................................................
14 ..............................................................................................................................................................................
15 ...............................................................................................................................................................
16 ......................................................................................................................................................
17 ...........................................................................................................................................................
19 ................................................................................................................................................................................
22 ........................................................................................................................................

:
24 ...........................................................................................................................................................................
25 ..........................................................................................................................................................................

 26 ...........................................................................................................................................................

:
27 ..........................................................................................................................................................................
30 ..........................................................................................................................................................................
! 32 ......................................................................................................................................................
37 ...........................................................................................................
B12 48 .........................................................................................................
3 6 54 ............................................................................................
57.....................................................
61 .........................................................................................................................................
! 64 ........................................................................................................................................
68 ...................................................................................................................................
73 ....................................................................................................................................
76 ...........................................................................................
79 .....................................................................................................................................................
83 ......................................................................................................................................

:
88 .............................................................................................................................................................................
) ( 91 ...........................................................................................................................................................

 99 ....................................................................................................................................................................................
102 ................................................................................................................................
124 ...................................................................................................................................................
134 ............................................................................................................................................
136 ................................................................................................................................................
147 ................................................................................................................................................................
153 ............................................................................................................................................................
164 .................................................................................................................................................................................
168 ...................................................................................................................................
172 .............................................................................
173 ................................................................................................................................
181 .....................................................................................................................................
183 ................................................................................................................................................................
263 ....................................................................................................................................
271 ..................................................................................................................................................................
274 ............................................................................................................................................
279 ..............................................................................................................................................................................
291 ...................................................................................................................................................................
298 ........................................................................................................................................................................

 323 ..........................................................................................................................................................
325 ....................................................................................................................................................................
327 .............................................................................................................................................
342 ...............................................................................................................................................
348 ...................................................................................................................................................
351 ...............................................................................................................................................................
355 .................................................................................................................................................
358 .........................................................................................................................................................................
359 .........................................................................................................................................................
366 .......................................................................................................................................
369 ...............................................................................................................................................................................
401 ..........................................................................................................................................................
402 ................................................................................................................
408 .......................................................................................................................................................








.
_ _
.

.
" " " "
.
. " "
.

.

.
http://www.zarinazar.com
http://drzarinazar.blogfa.com .


. .
"" " "
.

.


60 .


.
.
.
moin.ghn@gmail.com .

.
.

1391

) PCRM (Physicians Committee for Responsible Medicine

) 1995 ( . 4000
120000
... .
) NHA (National Health Association
.
.
Gerson Institute
.
) (Certificate Our
Place International
.
www.ourplaceinternational.com

 20
... .

.
www.healthministries.com
Dave Klein
) ( .
www.colitis-crohns.com

.

.

.
.
.



.



.


.

.
] [1
.

.
] [2 ] [3 ] [4 ] [5.

.
.
1.Dave Klein, Phd. www.colitis-crohns.com

2. http://www.PCRM.org

3. www.Gerson.org

)4. http://www.NHA.org (National Health Association

5. www.OurPlaceInternational.com

10

 :

:
. . .
.
.
70-60
. 90 .
. .
.
.
.
. .
.
. .
.
.
.
.

11

 .
.

.

.
.
. .
. .

. .


.
.

.
.
.
.

.

12

) ( .
.
.
.



.
.
.

.

13

 .

.

.
. .
.
.
.
.
.
.

.

14


.
.

. . .
. .
.
.

.

.
.
.
.
.
.

15

 .
.
. . .

. 3-4
.

:
.
.

.
. .


.
.
.

. .
.
.
.

16

 .
.
.
.
.

.

.

.
.

17

 .
.
.

.
.

. .

.
.
. .
.
.
.
. .
. . .
.
.
. .
.
. .
.
3-4
.

18

.
.
.

.
.
.

.

.
.

19



.
.
.
. 40-50
.
) (
.


.

.

.

:
.
.
. 5 .
.

2 .
.
. .
.
.

20


!
"" .
.

3-4
.

21

. .
.
.
10 20 2 .
.
.
.
.

.

22

 .
.
.
:

.
) ( http://www.phce.org :

23

:

.
.

.
. .

24

 :
.
. .
.
.
)( .
.

.
. .
.

.
.

25

 :
.
. .
.

.
.

.

.
.


.
) (

.
. .

26

 .
.
.
.

.
.

.
.

27

 .
. .
.

.
.

.
.
.
.
.
.
.
.
.

. .

.
. .
.

.


.
.
.

28


.

.
.
.
.

.

.

. .
.
.

.
.
.


.

29

.
. .
.
. .

.
.
.
.
.

.
.
.

.

30


. .
.
.
.

.
.
.

.
. .
. .
.
) ( .

31

 !
.
. .
.

.
.

. .
60 70% 30 40% %2 212
.
% 80- 70 .
. %30
: %5 -15 .
.
.

. .

. )(
[1].
[2].
) (Methionine . .
.
.
. .
.
[3].

) (ulcerative colitis [4]. [7] [6] [5] .
.

32

 . .
.
.
.
[8] .
. 8-15 .
33 37 270
.
.
.


. [10] [9] .
.

[11] . %60 -70 .
.
. .
.

4 8 [12] .
23 .
[13] . 12 [14] .
30 [14] .
[16] [15] .
] [17 .
. .
.
.
.
) (Cefitofur
.
[18] .
) (Avidin )
( .

33

 . .
.

.

. .
.
.
.
. .
.

.
.
.
.

) (Dioxin [19] .
.
85 44 23


[20] .
.

.
.
. .




_________________________________________________________________________________

34

References

1) Maurer M. Neutralization of Western diet inhibits bone resorption independently of K intake and
reduces cortisol secretion in humans. Am J Physiol Renal Physiol. 2003 Jan; 284(1): F 32-40
2) Remer T. Influence of diet on acid-base balance. Semin Dial. 2000 Jul-Aug; 13(4): 221-6
3) Troen AM. The atherogenic effect of excess methionine intake. Proc Natl Acad Sci USA. 2003 Dec 9;
100(25): 15089-94
4) Levine J. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol. 1988 Jan;93(1):837
5) Cellarier E. Methionine dependency and cancer treatment. Cancer Treat Rev. 2003 Dec: 29(6):489-99
6) Stubbs Ak. Nutrient-hormone interaction in the ovine liver: methionine supply selectively modulates
growth hormone-induced growth hormone-induced IGF-I gene expression. J Endocrinol. 2002 Aug;
174(2): 335-41
7) Epner DE. Nutrient intake and nutritional indexes in adutls with metastatic cancer on a phase I
clinical trial of dietary methionine restriction. Nutr Cacer. 2002; 42(2): 158-66
Morin RJ, Hu B Peng SK, Sevaninan A. Cholestrol oxides and carcinogenesis. J Clin Lab Ana.
1991;5(3): 219-25
9) Schrauwen P. High-fat diet, muscular lipotoxicity and insulin resistance. Proc Nutr Soc. 2007 Feb;
66(1):33-41
10) Egg consumption and the risk of type 2 diabetes in men and women. Biowizard.com Retrieved
2010-01-10

11) Yecies JL, Manning BD. Chewing the fat on tumor cell metabolism. Cell. 2010 Jan 8;140(1):28-30
12) Hu FB, Stampfer MJ, Rimm EB, Manson JE, Ascherion A, Rosner BA, Spiegelman D.,. Prospective
study of egg consumption and risk of cardiovascular disease in men and women. JAMA. 1999 Apr
21;281(15):1387-94
13) Surprising risks of egg consumption, American J of clinical nutrition
14) Stamler J, GreenlandP, Van Horn L, Grundy SM. Dietary cholesterol, Serum cholesterol, and risks of
cardiovascular and non cardiovascular diseases. Am J Clin Nutr. 1988 Mar;67(3):488-92
15) Egg Allergy Facts; Asthma and Allergy Foundation ofAmerica

16) Egg Allergy Brochure: distributed byRoyal PrinceAlfredHospitals

17) Arnaldo Cantani (2008), Pediatric Allergy, Asthma and Immunity, Berlin: Springer. pp710-713 ISBN
3-540-20768-6

35

18) Gulli, Cathy, Playing chicken with antibiotics injected into chicken eggs making Canadians resistant
to medications, Mc Leans magazine, June 17 2009

19) Parzefall W. Risk assessment of Dioxin contamination in human food.

Food Chem Toxicol. 2002 Aug;40(8):1185-9
20) Fung TT, Van Dam Rm, Hankinson SE, Low-carbohydrate diets and all- cause and cause specific
mortality: Two cohort studies. Ann Intern Med. 2010;153:289-298

36

) .
(

.

.

.
.
.

37


.
.

.

.


.

.

IGF [1,2,3,4,5,6,7] .
: 12
.
2009 ].[8
:
: ) ( ] .[9,10

.
.
. ) (Heme
) (Heme ].[11
:
] .[12
].[13
1960
.
.

.
.

38

 HDL
.
12 .

.
.

.
) (12.

.
.
Alpha lactalbumin .
.

.
12
.
:12 12
) (.
.
.

**

137

36

33

34

29919

17

39

31

293

1168

19

11

0.5

20

548

51

545

252

*
** ][15,16 ,14
:
Campbell, PhD, ColinT
The China Study Benbella Books, Paper back edition 2006, p230

100

11.2

5.4

11.6

182

2.4

257

2.2

0.7

7.9

40

71.4

43

643

88

2071

10.7

12

1.7

971

0.29

0.04

0.71

1.64

1.1

3.6

1.1

1.2

1.8

143

171

IU 6757

241

18571

3.2

55

1.7

41

:
Adams, C 1986 Handbook of the nutritional value of food in common units (New York: Dover
.(Publications

.
.
)( .
.
. 48 31
46 45 ].[17
12 .
.
.
.

.


.
.

.
) i

(
12 K .
.
12 .
.
.


.

42



.

.
.

.
. 8
.
.
][18,19
.
.

.
20 ) (Dean Ornish
) ( ] .[20

.
.
) (Esselstyn ]
[21,22
50 ] [23.
) ( 35
].[24
[25] .
50 : ] [26
: ][27
60 ][28,29
75 ] [30 .
45 ][31,32

250 ].[33

43


38 ][34
55 ] [35
200-300 ] [36
50
][37

.
4-5 )
!(
.
.
.

.


.




_____________________________________________________________________________________

1) Willett, W.C. 1997. Nutrition and cancer. Salud Publica Mex. 39(4):298-309
2) Marks, F., G. Furstenberger, and K. Muller-Decker. 1999 Metabolic targets of cancer
chemoprevention: interruption of tumor development by inhibitors of arachidonic acid
metabolism. Recent Results Cancer Res.151:45-67

44

3) Staessen L., D. De Bacquer, S. De Henauw, et al 1997 Relation between fat intake and mortality: an
ecological analysis in Belgium. Eur. J. Cancer Prev. 6(4): 374-81
4) Rose, d. P. 1997. Dietary fatty acids and prevention of hormone-responsive cancer. Proc.Soc. Exp.

Biol. Med. 216(2): 224-33

5) Giovannucci, E., M.N. Pollak, E.A. Platz, et al. 2000. A prospective study of plasma insulin-like growth
factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomarkers.

9(4):345-49
6) Bohlke, K., D.W. Cramer, D. Trichopoulos, and C. S. Mantzoros. 1998. Insulin-like growth factor-1 in
relation to pre-menopausal ductal carcinoma in situ of the breast. Epidemiology 9 (5): 570-73
7) Wolk. A., C.S. Mantzoros, S.O. Andersson, et al. 1998. Insulin like growth factor-1 and prostate
cancer risk: a population-based case- control study. J.Nat. Cancer Inst. 90(12):911-15
8) Position of American Dietetic association(ADA): Vegetarian Diets J.Jada. 2009. 05.027
9) Messina V, Mangels R, Messina M. The Dietitians Guide to Vegetarian Diets: Isusues and
Applications. 2nded. Sudbury, MA: Jones and Bartlett Publishers; 2004.
10) Hunt JR, Roughead ZK. Adaptation of Iron absorption in men consuming diets with high or low iron
bioavalibility. Am J Clin Nutr. 2000;71:94-102.
11) Eisman, George, M.A., Msc. R.D. A Basic Course in Vegetarian and Vegan Nutrition 2003 ISBN
0-961-4435-0-0 pp.69-70
12) Position of American Dietetic Association(ADA): Vegetarian Diets J.Jada. 2009.05.027
13) Davey GK, Spencer EA, Appleby PN,Allen NE, Knox KH, Key TJ EPIC-Oxford: Lifestyle characteristics
and nutrients intakes in a cohort of 33,883 meat-eaters and 31,546 none meat-eaters in the UK. Public

Health Nutr. 2003;6:259-268

14) U.S. Department of Agriculture. USDA Nutrition Database for Standard References. Washington
,DC: U.S. Department of Agriculture, Agriculture Research Service 2002. Accessed
athttp://www.nal.USDA.gov/finc/foodcomp
15) Holden JM, Eldridge AL, Beecher GR, et al. Carotenoid content of U.S. Foods: an update of the
database.J. Food Comp. Anal. 12(1999): 169-196,
16) The exact food listings in the database were: Ground Beef, 80% lean/20% fat, raw; Pork, fresh,
ground, raw; Chicken, broilers or fryers, meat and skin, raw; Milk, dry, whole; Spinach,raw;
Tomato,red,ripe,raw, year-round average; Lima Beans, large,mature seeds,raw;
Peas,green,raw;Potatoes,russet,flesh and skin,raw
17) Dr. Bernard Jensen, Guide to Body Chemistry and Nutrition, Keats Publishing, 2000
18) Spencer,Colin, The Heretics Feast, a History of Vegetarianism 1996
19) Harris, William, M.D. The Scientific basis of vegetarianism, Hawaii Health Publishers, 1995
20) Ornish,D, Brown SE, et al Can Lifestyle changes reverse coronary artery
disease Lancet 336(1990):129-133

45

21) Esselstyn,CB, Ellis GG, et al A strategy to arrest and reverse coronary artery disease: A 5-year
longitudinal study of a single physician practice J. Family Practice:41(1995):560-568
22) Esselstyn CJ, Introduction: Mpre than coronary artery disease Am J.Cardiol. 82(1998):5T-9T
23) Phillps,R., et al., Coronary Heart Disease Mortality among Seventh-Day Adventists with Differing
Dietary Habits,American Journal of Clinical Nutrition 31(1978):S191-8; Burr,M.,et al.,Vegetarianism,
Dietary Fiber and Mortality,American Journal of Clinical Nutrition 36(1982):873-7; Burr,M.,et al., Heart
Disease in British Vegetarians, American Journal of Clinical Nutrition 48(1988):830-2; Thorogood,M., et
al., Risk of Death from Cancer and Ischaemic Heart Disease in Meat and Non-meat Eaters, British

Medical Journal 308(1994):1666-71;Berkel,J., et al Mortality Pattern and Life Expectancy of SeventhDay Adventists in the Netherlands,International Journal of Epidemiology12(1983):455-9; ChangClaude,J., et al., Mortality Pattern of German Vegetarians after 11 Years of Followup, Epidemiology3

(1992):395-401
24) Resnicow, etal., Diet and Serum Lipids in Vegan Vegetarians. See also Messina and Messina, The

Dietitians Guide to Vegetarian Diets

25) Ophir O., et al., Low Blood Pressure in Vegetarians, American Journal of Clinical Nutrition

37(1983);see also Melby,C.L., et al., Blood Pressure in Vegetarians and Non Vegetarians: A CrossSectional Analysis,Nutrition Research 5(1985):1077-82., Melby,C.L., et al., Relation Between
Vegetarian/None-Vegetarian Diets and Blood Pressure American Journal of Public Health,

79(1989):1283-8
26) Ophir,et al, Low Blood Pressure in Vegetarians
27) McDougall, The McDougall Program, pp.222-3, see also Lindahl,O et al., A Vegan Regimen with
Reduced Medication in Treatment of Hypertention, British Journal of Nutrition 52( 1984):11-20;
Rouse,I.L., et al., Blood Pressure Lowering Effect of Vegetarian Diet: Controlled Trial, Lancet 1

(1983):5-10
28) Castelli, William, M.D., Director, Farmingham Heart Study, National Heart, Lung and Blood Institute
29) Neal Barnard, The Power of Your Plate: Summer Town , TN: Book publishing company 1990,

p.26
30) Health Professional Follow-up Study , reported in Dairy Products Linked to Prostate
Cancer, Associated Press, April 5,2000
31) Giovannucci E., et al., Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the
epidemiologic Literature, Journal of the National Cancer Institute,91(1999):317-31; see also
Giovannucci,Journal of the National Cancer Institute, 87(1995):1767-76
32) Journal of the National Cancer Institute 92(2000)61-8, cited in Vegetables Lowers Prostate Cancer
Risk,Loma Linda University Vegetarian Nutrition and Health Letter, March 2000; see also: Meat
Consumption Increases the risk of Prostate Cancer,. A new study on morethan 175,000 men in NIH-AARP

Diet and Health Study., Sinha R, et al., Meat and Meat-Related Compounds and Risk of Prostate Cancer

46

in a large prospective cohort study in the U.S.; Am. J. epidemiol. 2009;170:1165-1177

33) American Association of Endocrine Surgeons Presidential Address: Beyond surgery, Caldwell
Esselstyn, San Jose, CA, April 15, 1991; www.heartattackproof.com/address01
34) Singh,P.N., et al., Dietary Risk Factors for Colon Cancer in a Low Risk
Population, American Journal of Epidemiology 148(1998):761-74. , see also: Willet, Walter, et al.,
Relation of Meat, Fat, and Fiber Intake to the Risk of Colon Cancer, New England Journal of

Medicine December 13,1990; Willet qouted in Kolata, Gina, Animal Fat is Tied to Colon Cancer, New
York Times, December 13 1990; OKeefe, S.J., et al Rarity of Colon Cancer in Africans is Associatedwith
Low Animal Product Consumption, Not Fiber, American Journal of Gastroenterology 94(1999)1373-80
35) Ibid.
36) Ibid.
37) Ibid.

47

 B12

.

.

.
.

.
12
.
) (vegan
12.


.
12
.
12
. .
) 12 (
.
) (megaloblstic Anemia ) Pernicious
(Anemia .

48

 12
.
.
12
.
0.5 -1 ) . (
] .[1 2-3
] .[2
.
12
) (Inrinsic Factor .
. 12 )(
. 12 -3
2 5 .
.

12 .

. enterohepatic arculation
12 .

.

. 12
. .
12
. 12 )(
. .
12
12 .
12
.
12 .
12 .

49


.
12
.
.

.
12 .


12].[3

12].[4
12:
12
] .[5 12 )
( ] [6
.
1842
] .[7 12
12 .
) (
autoimmune 12 .

) (Sprue 12 .
12
12.
12 . ) (
) (Phenytoin
12 .

bacterial over growth 12
.
) (Fish tope worm
.

50

 12
.

.
.

12 .
) (
. 12 .
.
12
. 12
.
12
.
12 . 12
. (methyl
)malonic Acid .
.
12
.
. . 12
].[8
.
6 .
12
) (12
. i Nori
] .[10][9 . 12
12 ) .3 (.
12
) (

51

 ) 12!(
12 .

].[11
0.3-0.6 12 .
500-5000 . 12 .
.
[12].
12
.


. . 12
.
6 12 .
12

References
1) Textbook of gastroenterology, volume I TADATAKA YAMADA Second Edition, p469
)2
3) Graham, Dr. Douglas N; The 80-10-10 Diet; FoodnSport Press. 2006
4) Peavy, W. and Peary, W.; Super Nutrition Gardening; Avery Publishing Group. 1993
5) Guyton and Hall Text book of medical physiology; Eleventh Edition, P.877
)6
7) Chanarin I. Historical review: A history of pernicious anaemia. Br J Haematol. 2000 Nov.
;111(2):407-15
8) Wierzbicki AS. Homocysteine and cardiovascular disease; A review of the evidence. Diab Vasc Dis
Res. 2007 Jun;4(2):143-50
9) Watanabe F, Takenaka S, Dried green and purple lavers(Nori) contain substantial amounts of

52

biologically active vit. B12

10) Croft MT, Laurence AD Algae acquires vit. B12 through a symbiotic relationship with bacteria.
Nature. 2005 Nov.3;438(7064):90-3
11) Koebnick C, Hoffmann I,..Long term ovo-lacto vegetarian diet impairs vit. B12 status in pregnant
women. J Nutr. 2004 Dec.;134(12):3319-26
12) Freeman AG.

Hydroxy cobalamin versus Cyanocobalami. J R Soc Med. 1996 Nov.; 89(11):659

53

 3 6

. 9
4 .

.
. Monounsaturated
Polyunsaturated .
.
.
.
.

.
.
. 3 6.

)( .

54


3 6
.
6
. .
3 .

6

.

3 .
:3 3 .
6 3!

3
.
3 .
3
.

.
.
3 - - 3 .
) 2
( . )(
.

55

 )
( ) (
3 6 .
3 6 :
) ( .

56

.
.
.
.
.
.

.

) (autoimmune .
) MS (Multiple Sclerosis
.
.
.
.

. .

.
.

57


) (Bovine Serum Albumin BSA
.
D .
D .
D ) (Cytokines .
. D
. .
D1.25 .
D
D1.25.
D . D1.25
D .
.
. .
.
D1.25 .
D
.
D
.
) (Insulin like growth Factors, IGF
. .
.

.
.

58

 ) ( .

. .
. .

.
.
.

.

References
1) Karjalainen J, Martin JM, Knop M et al., A bovine albumin peptide as a possible trigger of insulindependent diabetes. N England J med. 1992; 327:302-7
2) American Academy of Pediatrics work group on cows milk protein and diabetes mellitus. Infant
feeding practices and their possible relation to the etiology of diabetes mellitus; Pediatrics 1994; 94: 75254
Cell mediated immune response to beta-casein in recent onset
Lancet 1996; 348: 926-28

3) Cavallo MG, Fava D, Monetini L,

insulin-dependent diabetes: Implication for disease pathogenesis.

4) Outwater JL, Nicholson A, Barnard ND. Dairy products and Breast cancer. The IGF-1, estrogen and
BGH Hypothesis. Med. Hypoth. 1997; 48:453-61
5) Gregorio DI, Emrich LJ, Dietary fat consumption and survival among women with breast
cancer. J Natl cancer Inst 1985; 75: 37-41
6) Holm LE, Callmer E, Hajalmar ML, Dietary habits and prognostic factors in breast cancer, J
Natl cancer Inst 1989; 81:1218-23
7) Cramer DW, Willett WC, Bell DA, et al. Galactose consumption and metabolism in relation to the
risk of ovarian cancer. Lancet 1989; 2:66-71
;8) Ratner D, Eshel E, Juvenile rheumatoid arthritis and milk allergy. J Royal Soc med 1985

59

78:410-13
9) Remer T, Manz F, Estimation of the renal net acid excretion by adults consuming diets containing
variable amounts of protein. Am clin nutr 1994; 59: 1356-61
10) Feskanich D, Willett WC, Milk, dietary calcium and bone fractures in women: a 12-year
prospective study. Am J Publ Health 1997;87:992-97
11) Van de Laar MAFJ, Van der Korst JK, Food intolerance in rheumatoid arthritis. A double blind
controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Ann Rheum Dis 1992;
51:298-302
12) Also same authors , Food intolerance in RA. Clinical and histological aspects. Ann Rheum Dis
1992;51:303-6
13) Chan JM, Stampfer MJ, Ma J et al, Insulin- like growth factor-I (IGF-I) and IGF binding protein-3
as predictors of advance stage prostate cancer J Natt cancer Inst; 94(2002): 1099-1109
14) Norris JM, and Pietropaolo M, Review article; controversial topic series: Milk Protein and Diabetes. J
Endocrinol. Invest. 22(1999):568-580
15) Swan RL, Multiple sclerosis: correlation of its incidence with dietary fat Am.J.Med. Sci.;
220(1950):421-430
16) Dip JB.

The distribution of MS in relation to the dairy industry and milk consumption; New

Zealand med. J 83( 1976): 427-430

17) McDougall JM. 2002 MS stopped by McDougall/ swank
program,http:www.nealhendrickson.com/mcdougall//mcdnewannouncementswank02112.httm.
November16,2002
18) Malosse D, and Perron H. Correlation analysis between mild and dairy product consumptionand
multiple sclerosis prevalences: a worldwide study. Neuroepidemiology 11(1992):304-312
19) Bronsan JT, and Bronsan ME, Dietary protein, metabolic acidosis and calcium balance, In:H.H.
Darper(ed.) advances in nutritional research, pp.77-105 New York: plenum press, 1982
20) Savilahti E, Akerblom HK, Children with newly diagnose insulin dependent diabetes have
increased levels of cows milk antibodies, Diabetes Res.7(1998):137-140
21) Yakota A, Yamaguchi T,

Comparison of islet cell antibodies, islet cell surface antibodies and anti

bovine serum albumin antibodies in type I diabetes., Diabetes Res. Clin. Pract. 9(1990):211-217

60





.
.
.

.
.
.

.
.
.
.
:
. 1886
.

. .
75 .
) 138
152 ( . .
) (mycrobacterium
.
. Whey
. .
.
.

61

 .
.
.
.
. ) (
.
.
.
.

.
.
. .

. .

.
.
. ) . PH (.
.
.
) (A ) (D .
PH .

.
. ) (


.
. .
.
.
.
.
) (IGF-I

62

 . .

.
.
.

.
.

.

.

63

 !

:
.

.
.

].[1
.

64

 .
.
)( 13 ][2
.
:

][3
) (Ereetion )
(
][4
) (
] .[5
.
.
]6.[7

.
]8.[9
)
(
.

.

.
Supersize me .

65

 .
) (
.

.
.
.
.
.
) ( ) (Xenoestrogens.

) (Wild Yam .
.
.

.

.
References:
1) Roos G. Men, Masculinity and Food: Interview with Finnish carpenters and engineers. Appetite.
2001 Aug;37(1):47-56
2) Allen NE. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgen in
vegan men. Br J Cancer. 2000 Jul; 83(1):95-7
3) Feldman HA. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts
male aging study. Prev med 2000 Apr; 30(4)328-38
4) Walczak MK. Prevalence of cardiovascular risk factors in erectile dysfunction J Gend specif med. 2002
Nov-Dec;5(6):19-24

66

5) Bodie J. Laboratory evaluations of erectile dysfunction: an evidence based approach. J Urol.

2003;169(6):2262-4
6) Suzuki S. Intakes of energy and macronutrients and risk of benign prostatic hyperplasia. Am J Clin
Nutr. 2002 Apr: 75(4):689-97
7) Divisi D. Di Tommaso S, Salvemini S, Garramone M, Diet and Cancer. Acta Biomed. 2006
Aug;77(2):118-23

Allen NE. Hormones and Diet: Low insulin-like growth factor-I but normal

bioavailable androgen in vegan men. Br J Cancer. 2000 Jul;83(1):95-7

9) Rozuti R. Role of environmental estrogen in the deterioration of male factor fertility. Fertil Steril. 2002
Dec;78(6):1187-94

67

) (

.
-


.
.

68




.
.
.

. .
.
-
(1 .
.

.
.
(2 IGF-1
.

rbGH, recombinant growth hormone

.

69

- Cancer Gene Therapies, 2000 Mar, 7:3

FDA review of genetically engineered milk, Science, vol 249, 8/12/90
-Journal of Institute of Health, 1993, 3
(3
.
.
.

:
Pediatrics-Allergy-Immunology, August 1994, 5 Supplement
(4 .
.
.

Diabetologia, 1994; 37The Lancet, October, 1996, 348The Lancet, Dec 14, 1996Pediatrics, July 1992;89 (5 .

T.Colin Campbell, PhD , The China Study, pp 65-66 first edition 2006
(6

70

 .
.

Nutrition Action Healthletter, June 1992;50

(7 .

.

-The Lancet, ii; 205-20Survey of Mortality Tates and Food

Consumption Statistics of 24 Countries, Medical Hypothesis, 7:907-918, 1981European Journal of Clinical Nutrition, 48, 1994
(8

.

:
Journal of Dairy Science, 1991;74(11
Endocrinology, 1999 Sep, 140:9
(9 . " "
.
.

71

 .


(10
. .

.


.


"" "" .

1389

72


) (

.
.
.

.
.
!

.

.
.

73


.
.
.
.
.

.

.


C .

.





.

.
.
.

74

 .
. .

.

.

.

.

75


100-150
.

.

.1
.

.
.

.





.
.
.2
.
.
.3
.
.

76

 .
.

! .
.
.4
.




.
.5 .


.

.

.
.
.

.



.

.
. . .
.

77


.
.
.6 . .
.
.

. .
. .
.
.7
.
.
.
.8 .
.
. . .
.

.
.9
. .


.

.
.10 .

.

78


.
.

. .
.
.
.

.
.
.
.
.
.

.
:
.

.
.
.
.
.
.

79




.
.


.
.
.
: .
. .

.

.
) (
.

.

.

.

.
.

.

80


.
.
.
.
. .
.

.
.

.
.
.

.
) ( .
.
.

.
.
.



.
.

81

 .
.
. .
.

82


. :

.
.
.
:

. .
. ..
.

83

 .
.
.

. !

.
.

.



.

.
.

.
.
.
. .
.

.

84

 80
. -85
80 .
:
.
. .
.
.

.
.

.
.
. .
.

.
.
.

.

.
:

85


. .
.
:

) 6 ( :
.
: . .
.
:




80-85
.
.
.
:
) (
.

86

 12 . 12
) (Methyl Malonic Acid .
. .

. .

.
) (
.
.
.
) (
.

87



90 .

.

.
:

" "
.

""
.


!
.

88


.

.
.




"" .
.
.

.

.
. .
.
.

89


.
.

"" .
""
.
) 80 20
(

.
.

.

90

 )(
:

.
.
.
20 .
.
.
.

. .

.
.

91

 .
.
) (
.

.
) (
.
)
" " (

.
.

.

.
.
.
.
. .
.

: )(

. 43 . .... . .

92


.
.

.

.

.

. .

.
...
.

.
) 10-7(
) ( .
. .
.
.

93

 . 43 . .... .
.

.
.

.

.

)
(....
) (
.

.

.
.
.

)( .

94

. .

.


.

.
.
.
.

: ) (

. .
.
) ( .
5 .
.

.

95

 . 5
.
.
.

.
.

: ) (

54 8 .

)
(. .

.
.
.
.
.
.
5-3
.
.
.

) ( .

96


.
.

.

)( .
.
. .
.
Dr. Herbert Shelton
:
www. Ourplaceinternational
.
Truenoreh .
. .
.
.
.

:





:
.
.

.
.

97


. .
. .

...
. .

.
)
(... .

. .
. )(
.
) ( .
.
. .

. . .

) ( .

. . .
.
.

98

.
.

. .

.
.
.
.
.
.

99

 .
/ .
.

. .
.
.
.
. .
.
.

.

.

) ( .

.
.

.

)( .
.
. .
.

100

 Dr. Herbert Shelton

:
www. Ourplaceinternational
.
Truenoreh .
. .
.
.
.

101

. 18 7 3 . 4 .
3
. .
.
.

. .
.
.
.
.
.
.
. . . .
.

102


. .
.

.
.
3-2 ) (
. .

. .
.
.
.
.
.

.
.
.
.

:
.

103

:
24 ) ( .
. .
) (.

. .
.
) .
(
.
.

.
.

.

.
.

33 . 8 .
.

. .
. .

104


.
.
.

. .

. .
.
.
.
) . (
.
.

:
.

. .
20 . .
. .

. .

.

105


) (... .
:
.
.
.
.
.

.
.
.
.

6 .
.
.

45 95. 178 . hbsag+
)4 ( . ) (24 2 .

.

.

106



. .

.
.
.
.
. .
.

.
)
( .
.
.

. .
. .
.

. 48
.
.

107


,
.

. .
.
. 12
.

.

.
.
) ( ...
.
.

: .
:
.
.
) ( .
: ) (....
.
.
.

. . .
.
.
.

.
) " "
( .
.

108

. 59 168 76 . 85 73 .
3 . .
.
. . ) ( .
) ( . .
. .
220 . .


.
.
. .
. .
.
.
.
... . .
.
.


.
. .
) ( .
.
.

10 5 500
bicaspid 20 .

109

 . . 49
.

.
!
. .
Self Healing crohns and colitis , by Dr David Klein
.
.
.

.
.

.
) . (
.
. .
.
.

25 . ) isb ( .

110

 3 lactal cilidiniium domperidon hexal colofac ) sertrabiol 100

( 2 ) minirin ( apo- doxepin
10mg .
. .

.

.

.

.

.
) ( .
.

.

"" . .
.

.

. .
.
.

:
.


:

111

 .1
.

.
.
.

.2

)(ibs . ibs
.
. .

.

33 78 150 .
. . .

.
.
.
.
.
. .
- .
.
. :
. .
. .
.
. .

112

 . .
. .
.
...
.
.

.

. .
.
2 3 .
6 .
) (
.
.
.
.
.
.
.
.
.
.
) . (

.
85 95 15 10
. .
. .
.

. .
.

.

113

 . .
.

50 .
. . .

.

3 6 .

.

.
. .
. .

. 50 12 .
.
. . . .
.
.

114



.

.
.
) ( .
.
.
.
.
.

:

)39( .
10
.

.
. .
. .

.

.

.

115


)( .
)( .
. .
.
.
. )
(
. ) ( )
( ) ( .
.
. .
.
) ( . .
.
) ( )
(

.
.
. .
. .
.
.

.

.

.
. .
.
. .
.
.
. .

116

. .
.
. . .

.
.
.
.

.
) ( .
.
:
.
.
. .
.
.
.
. .
.
.

.

. .

117


.
...
.

.
) 10-7( ) ( .
. .
.
.

.
. .
12 .
12

...

12 .
12 .

118

 .

) . 126 (118
.
.
.
.

.




. .
.

.
.
.
.
.

119

 .
.
.
.

.

. .
. 85 95
.
.
.
) (
.
.

.
...
.

.
.

. 4 .

. .
.

24 ) 54 ( 168

120


.
.
.
.

12 .
.
) (
.

:
... ...
. ...
. 10 2
.
. .
... ) 15 .
(.
.
) (
3 . ..
:


.
.

121

 .
.
.

.
. .
) ( .
4
) (
) ( .
.

: +

. 5
.
.
:

.
.
.
. .
} .
{

.

.
.

122

 . .

: )(

. 43 . .... . .

.
.

.

.

123

. 2 13
. .
.
2 12 8
50 .
) ( .

.

.

. .
.


.
) (
. ..
.
.
.
.
. .
.

124

 . ) (
"" . .
. . .
. . .

. .
. .
.

.

.
.

.
.
.

125

 ... .

. . .
.

16 45 . 150 .

. .

.
.
.
.
24 .
) ( .
.
.
.
.
.
.
.
.

126

 . . .
.
. .
. .
.
.
.
.
.
.
.

: 33 +

. 33 )( .
.
. .
:

.
) (
.
.

. .

.
)(
.

127

.
4 .
. ...
apo doxepin . .
. . Elocon . .

. .
.

.
.

:
.
. .
:

.
.

.
.
.
) . ( . .

128

 .
.
.
) . (

. .
.
" .
"
. .
100 -85
15 -0 .

.
.

. 29 .
. .

:


.
.

.

129

 . .

.
.
.

18 ... .
)(
) (
.
) (

) (
.
.
.
.
.
.

.

130

 .
.
) (
.
.
. )
( .
. .
.
.

.
.
.
-1

12-8

-2

) ( . .
-3
)
( .
. .
.


-4
.

131

 .
. .
. .
:
) ( ) ( )
( . .
) . .
(.
) ( ) . ( )
( ) ( ) ( .
< [-o
.
.

. .
) (
.

.

.
:
.
. 24 .
. .
.

132

 .
.
.
.
.
.
.

133

 . 29 .
. .

:


.
.

.
. .

.
.
.

. .
.
. .
betaserrc 8 .
37.....


. . . .

134

 .
.
.
.

. .
. ...
.
. .
.
... . betaserc betahistine
8 .... . ) ( .
. .

135

 .
.
.
.
. .

!
. .
.
.
.
.
. .

:

45 . . 100
. 4*11. .
) (

. .
.

"" . .
.
.

136

 . .
.
.
. 5 6
.
.

. 33 15 4 .

. .

.
.
.
.
.
.
.

.
. .
.
.

137


pco

. Pco . .
. )(
.
.
.
.
.
.
.
.
.

. ) (Xenobiotics .
.
.
.
.
.

.
.
.
.

138

 . ) (Parabenes
) (Conditioner .
Dioxin .
.
.
:
.
.
. ) (Paraben
)(Phenoxyethanol BHT .
. .
: .
. . .

. .

.
.
.
80 .
.

139


) .
(
.

.
.
.

:
.

.



.
.
. .

. .
.

2

.
34 ! ) 78(

140


.


.
) (
. .
.

) ( .
.
12 .
. .

--------------:

:
/
.
/
.
/ .
.
. .
)( .
.
5 .
.
.
. .

141

 .
.
) (
.
:
.1 : )
( . .

.
.
.2 : .

. .
.
) (
.

.
. .
.3 : . . .
. .
.
.4 :12
.
12 . 12
. 12
.

142

 .5 : .
. . )(
.
.6 : .
) ( ) (Flax seed .
.
) ( .
.
:
* .
.
.
* .
* .
* )!( .


.

.
.
* .
1700 1987
.
.
2 .

143

 1
.
.
.
.

.
.

.

. 40



.

.

. .

.
24-12
.
.
.

.


.

144

 .
.
.
.

. .
. ) ( .

.


. .

.
.
.


.
.

145


:

.

.
.
.
. .
.
.
.

.
) ( 95 -90
.
.
.
.
.
.

146


:
.

.
.
:
.1 .
.2

. .
. Max Gerson
.
.

. .
.
. .
.
.

... .

147



.
) .

( www.gerson.com

.
.
.
... .
.
.
... . . .
. . . . . .
!
.

:
.

53 . . .
.


.
. . .

148

. .
.



.

.
.
.

.

.
.
.

.
.

39
..

. .
.
.

149



.

.
.
.
.
. .
.

.
.
.
.
.

.

.

.
.
.
.
.
.
.
.

.

.
) (
.
. .

150

 .
.

. 50 12 .
.
. . . .
.
.

.

.
.
) ( .
.
.
.
.
.

33 . 8 .

151


. .
. .

.
.
.

. .
. .
.
.
.
) . (
.
.

152


:
.

51 . 40 .
.

153



.

.
. .
.

.
.

33 . 8 .
.

. .
. .

.
.
.

. .

154

 . .
.
.
.
) . (
.
.

33 78 150 .
. . .

.
.
.
.
.
. .
- .
.
. :
. .
. .
.
. .
. .
. .
.
...

155

 .
.

.

. .
.
2 3 .
6 .
) (
.
.
.
.
.
.
.
.
.
.
) . (

.
85 95 15 10
. .
. .
.

. .
.

.
. .
.

156

 :

145 168


7 25


:
.
.

.
.
.
.
!
.
- -
.
.
.



.



.
.1

157

 . .

. : .

.
.2 . . .
. .
... .

. ) (
.
.
.3 ... .
.
.
.

. .
.
. .
.
.4 :
.
.
.
) ) ... . .
.
- .

158

 . . . . .
. . .

.
.
. .
. . .
.
. 3-5 .
. ) ( .

.

.
. .
... .
. . .
. 2-3 . 3-4 . .
. . .

159

 . . .
- . .
. . . . . .
.
.
. . .
.
.
:
. .
.
. ) ( .
. .
.
.

: )(

. 43 . .... . .

.
.

.

160

: 2

. . )123
175 ( . 2
.
. 15 10
.
) .
( 15 .
) (
. .
. .

.
.
.
.
"" ""
.
.
: 80
.
.

.

161

 .
.

. .
.
.
.
.
.
. )
( .

.

. .
.
.
.
: . . )
(
.
.
.
.
.
:
. .
: .
.

162

 .
" " .
.
. . .
.

24 .
7-6 . .

.
.

.
.
.

.
.
.

.
.

163

. 50 12 .
.
. . . .
.
.

.

.
.
) ( .
.

164

 .
.
.
.

. 33 . 3
145 . 1000 . 45
117- 110 -100 .
.

.
:
80 20
-1
) ( .
. .
-2
.
.
-3
.
.
.
-4
. . .
.
) (
-5
6 . .
-6
.

165

80 .
. .
. .
.

: 2

43 171 77 2 . 7 . 40
.
40 7
.
: .
.

.
.
.
.
.
.
6 12 .
.
.
.

166

 .
.
.
.
. .

. 59 168 76 . 85 73 .
3 . .
.
. . ) ( .
) ( . .
. .
220 . .


.
.
. .
. .
.
.
.
... . .
.
.

.
. .
) ( .
.
.

167

. 50 12 .
.
. . . .
.
.

.

.
.
) ( .
.
.
.
.
.

168

. . 5
) (
. 2
.

. .
.
.
.

.
.
. .

.

33 78 150 .
. . .

.
.
.
.
.
. .

169

 - .
.
. :
. .
. .
.
. .
. .
. .
.
...
.
.

.

. .
.
2 3 .
6 .
) (
.
.
.
.
.
.
.
.
.
.
) . (

.
85 95 15 10
. .

170

 . .
.

. .
.

.
. .
.

171


: Minirin

. minirin .
:


.

.


.
.
.

.

172

.
9 . .
. 5


.
.
.
.
.

.
80 85 .
.
.
.

:
.

. 30
.

. 5
.

173


. .
.
.
.

.

. .

:

. 42 25
) ( .


.
.
.
) .
. (.

: D
.1 D
.2 D

174

 .3 D
:
D .
D .
D .
.
D . 15
D .
D Hudroxy 25
( vitD 25 ) D hudroxy 25 25 D
.
D
. D
.

-------------------------------------------------------------------------- :

. 9 ) (
ferritin 8 ng/ml
.

.
)
( .
)(
.
.

175


.
.
. . .

.

:
.

4 . . 4 .
.


.
.
) ( .

.
.
. .
.

) . (.

:
.

.

.

176

 .
. .

. .
.
.
.
.
.
. .
) (Dulse ) (kelp .
Bladder wrack .
85
.
.

:

31 3 5
. ) (
. gerson
13
.
. 1 .
2 3 .

177

 85
.
.
13 ) (
. 3
. .
.

.
.
.

. . .

:


2 %100 .
) ---
) ) -- - -- - -
) - )

178

 4 67 63


10 ) ( 10
)2 ( .



.
:
. .
..
.
.

.
.
. %80-85
. .
.

:
.
. .
-1
. .
) (

179


-2

-3

.
.
.
.
.
. .
.
. . .
. . .
.
. .
.
.
.

. 85 .
. .
.

180


: ) (

54 8 .

)
(. .
:

.
.
.
.
.
.
5-3
.
.
.

. 76 .
djd . .

:

.
.
.

181

 D
.
- .
.
.
8 12 ) (3
.

182

:
.
.
.
20 .
.
.
.

.
.

.


. .
. .
.
.
.

183

 8 .

.
.
.
.
.
.
.

:

:

.


. .


.
.

.

. .

184


.

.
60 .
.
.
.


. 1983-1992
.

.
--------------------------------------------------------

:

.
)( .
.
:
.1
.2 ) (
.3
.4 .

185

 .5 ...
.6 .
.7
.8 ....- - - -
.9 )
(
.10 :
.
:
.1 .
.
.
.2

.
.
)( .
.3 .
) ( .
.
.4 .
.
.
.

186

 .5 .
. .
.
.
.
.
.
... .

.
.6 .
.

.
.
.
.7 PH .
.
. i .
.
.
.8
.
.
20-50 .
...
.
) (

187


.

.
.9 .
. .
.
.10
. .
.

.
.

.
.

:

. .



. .
. .
.

188

 . .
.
.
.
.
.

.
. .
.
.
.

:
. .
.
:
) (
.
.
.

.
.
.
.

189

:

:
.

.
.
.
.

.


.
.
4 5
.
.
) ( .
.
.

:



:
.
:

190

 .
18.5-23.5 . 18.5
23.5 .
.
.
.
.
.
. ...
.
.
.
. 85-100 0-15
.
:
.1 .
.2
.3 .
.4 .
.5 .
.
.
.
.
.

.

191

 .
.
.
.

.
) ( .
.
.

.

:
) (
:
.
.
.

:

:
. ) (
.
. .
. .

.
.

192

:

:
. .
.
.

3 21 . 4
:
-1

-2

"16"

-3

-4

" "

-5

-6

"
-7
"
:

-1

-2

" " .

193


. .
. .
.
:
. )(
.
.
. .
.
.
.
.

.
3 .
3.
.
.
.
:

:
.

194

 .
.
.
12 .
.
.

:

:
.

.


.
.
.

/ .
.
.
.
. .

195

 .



!
.
.
) (chips .
:

75-80

...

) ( )

...

196

80 .
) (
.
12 24 .

.

!
!
.
.

.
.

. )
( .

) ( .
.

197

311 . .

.

.
.

.
.

.
.
.
.

.

.


. .
. . .

198


.
" " .
20 .
""
.

) ( .

. " " * .
.
. .
.

:

:
/
.
/
.
/ .
.
. .
)( .
.
5 .
.
.
. .

199

 .
.
) (
.
:
.1 : )
( . .

.
.
.2 : .

. .
.
) ( .
.

.
. .
.3 : . . .
. .
.
.4 :12
.
12 . 12
. 12
.
.5 : .
. . )(

200

 .
.6 : .
) ( ) (Flax seed .
.
) ( .
.

:
. .
.
. . )!( .
.

.
.
. 1700 1987
.
.
2 .
1
.
.
.
.

201

:
) (Fruitiarians
.
)
.
(
) .
(.
.
. .

.
) ( .
.

.
.

:


.
.
: ) (.....
:
: )(

202

 :
:

:


.
.
.
.
.
.
) .
4 5 (
) ( .
) (
. .
.
.
.
.
.
:
) .
( .

203

 24-12 ) . (
.
) ( .
.
.
.
) 7-5 (
. .
. .
.
. .
.
.
.
) (buck wheat
.
.
. .
.
.

. .
.

204

:
. .

.
. . .

. .
. !

:
.
.
:
.
) (
.
. .

. )
3-4 ( .
.
.
:
75-80 ) (
.
Processed Food
. Junk Food .
.
... ... .
) ( .

205

 .
.
.
.

.
.
.
.
.

.

: 12
(..
... 12 ...

:
.
B12 ) ( .
B12 . B12 7-8
B12
. .

:

:
.

206

 .
.
.
. ) 3 ( .
) (isoflavones .

.
.
(genetic engineering). )
( .
.

) ( .
) (phytoestrogen .
.
.

.

.
.
.

.


.
.
.
.

.

207

! 84 90 .
10

8
!
.

. 12
.

.

. .

.
.

:

:
.
.

. : .

.

208

 .
.
.
.

.
.


.
.
.

...
) ( .
.


.
!
.
) (
.
.

.

:
.

:

209

 .
. ) (Lycopene
.

.
.

10-14 . .

.

.
.

:

:
.
. .

.
.
.
.
.
.

210

:

. 4/5
11/2

. )
( .
.
.
.
.
) (ADA
.
. ) (
. .
. .



.
.
.

.
(Colin
)Campbell ) (The China Study
.
.
.
.
) (
5% ) 1/5
( . 5-6%

211

 . 10% .
4 2000 25 -50
) ( 2000 10%/4 = 50

.
.
.
. 18%
50% . .

:

:
. .
.
80
. .

) .
. (
.
) ( .
) ( .
. .
.
.
. .
.
.
.

212

 .
.

:

:
.
.

.
.
. .
) (Phytates )
( . .


.
.
:
.
) (Phytates .
.
.
.
.

.
. .

213

 :

. .
. .
.
. .
.
. .
.
. .
. !
.
:
.
. .
.
.
.
.
.
.
. ) . .
( .

. .
.
.
.

.
. .
.

214

 .
.
. .
.

:
-1

-2 4
6
-3 : ...

.

.
.
. )
( .
.
) ( .

215


. .
. .
.
.
.
.

. .
.
.
.
.
. .
70 .
) ( )
(... .
30 . 60
24 .
.
.
) .
(.
)
( .

.

.

216


. .

6 8 .
.
.
.


.

.

: ) (

Heal yourself
Blender
.
.
.
.

.

217



.
.
.
.

.
.
.

. .
.

.


.

.

.

.

.
.

218


.
.
.
. . :
. 75- 85
.

.

.
.
. .
.
.
. .
. .
.

. .
.
.
.
:

219

 :
:
: ) (
.
.
.
.
. A
.
.

.

.

: ...

:
-1

12
-2
12
12

220


-3

... 12
-4
.... .

( 1
.
. ) (
.
.
(2 12
. 12

.
.
.
. . 12
) (
. .
(3 . .
.
(4 12 24
.

.
.

.

221


.

.
.
.
. .
.
.
natural Hygiene
.
.

:

23 .
. .

. .
. .
) (
.
.
) ( .
) ( .
.

24 -12 )( .
. .

222

 ) 40 (
.

.
.
.
.
.
.

. .
.
.
.
.
.
.

:

31 178 . 75 85
10 .

.
) (

223

 ) (
10 .

.
) (

.
.
...
.

.
.
.
.

.

. 5 ) (
. 5 6
.
5
.
.
...
. .

)
( .
.

224



!

.

.
. .
.
.
.
.
85

.

.
.

:

.

:

.

.

.

225


.

.
.
.
.

.
)
( .
.

.

.

) ( .



)
( .

.
) ( .
5
.

.

226

 . .
.
.

.
.

:
.

.

:



.
.
1996 .
90 .
.

.

227



) ( .
) (FDA

. .
:
.
.

.
.
50 .
.
.

.

.

. .

!

:
.

:

-1

228

-2

6
-3

-4

-5

-1

) 12 12 .
(
. 12
.

-2

3 3
.

.

.
.
3 .
.
-3
.

-4
.
. .
.
-5
.

229


.
.
.

.
.

.
.
.
.

) (www.VeganForum.ir .
.
.
.
.
. .

.
.
.
. .

230

 .

) ( .
.
. .
.
D .
.

:
35 159 47

. 30


.
:
. . .
.
.

.
.
30 . .
.
. . .
.
.
.

231

 . .
.

. 7 . 101
12 .

18
b12 .
. .

. )3 (

.

. .


.
.12 .
) ( 12
.

232

 . 3 4
. .
.
)* : "
"
.
. 4
(...
.

.
.
. )(
) ( .
.

24 -12 .
.
. ) (.
.

) (
.
.
.

:
1997
) (
. ) (
.

233

 .
.
:
5
.
.
. 12
.
.
9 8 .
.



.

.
.
12-8
-1
-2

) ( .
-3
. )
( .
. .
.


-4
.

234

 :

.
:
.
.
.
.
.
.
.

: B12

12 8-7

12 .
.
12 .

12 .
12 .
. .

235


) ( . 12
12 . .
.
.
.

.

. 13
1 . )
(
.
-2
) (...

. .
. .

.

.

. .

236

 .
.
.
:

.
.
.
.

. .
.
.

.

" " .

: 13

13 .
.

.
. .

.
.
.

237


.
.
.
12 . 12 .
.
.
" " .
:
www.zarinazar.com

" " .
.
.

:
.

. .
.
) ( . .

238


.
.
.
.
.
) (
.
) ( .
.
.

.
.

.
.
) ( .

.

.
.
.

.
.

239

. .
.
. . .

.
.
.
.

.
) ( .
.
:
.
.
. .
.
.
.
. .
.
.

240


.
. .

.
.


.
) ( .
12 .
.

2

.
34 ! ) 78(

.


.

241

 ) (
. .
.

) ( .
.
12 .
. .

. .
.
a.d . .
.

:


.

.
15 .
.
.

.
.

242

25 50 175 . ...

50 8 .
2 50 .
60
... :
) ( ) ( ) (
) ( ...
... 12
12 .
. !
. " " .
-1 -2
. .

. 25
.

. 19 178 50 . .
.

.
.
.
.
.
. .

243

 .
.

.

.

.

) ( .
.
.
.

.

) (
.
.
. .
.
.

.
.

. .
10
. . .

244

.

) ( .

.
.
.
.
.
.
...
.

.
.
.

.
.

245

 .
.

: 7

) ( 7 5-4
. . 75 80 .
. .


.
. .
) ( .

7 .
.
. .
. . .

:
15
7 .
. 63 190.

246

:


.
.

.

.
. .
. .
.
.

.

) (

.
.
.

.
24 7-6 . .

247

 .

.
.
.

.
.
.

.
.

. .

) ( .
.


.
.
.

248

 .
.

... ... ...

.... .

.
. .
.
.
)
( .
.
.
. .
.
.
.
.
.
)(
.

.
.

249

 ) ( .
.
. .
.

.

.

. .
5 10
.
100 3 5 100 .
.
.
.
.
.
.
8 .

.

250


.
. .
.

.
" "
.


.
.
.
.
.
.

. .
.

.
.

.

251

 .

... .
) ( .
.
. .

.

.
.
. .

)( .
)( PH ..
PH .
.
.

.

.

. .

252


.


.

. .
.
.

.
.
.
.
.
) (
.
.
.

.
.
.
.

5 ..

253

. .
.
foodnsport.com Doug Graham .
.

.

.
.
-

.
.

.
.

.
.

254

 :
.


:
.1
.

.
.
.

.2

)(ibs .
ibs .
. .

.

:






.


.
.

. . .

255

 .

.
.
.
.
.

.


...
85-100

.
. .
.

. .
Dehydrator
.
118 .
.
.
.
.
118 .
. 118
.
.

.
. .
. 90-95 .
.

.

256

 .
.

80 .
" "

.
.


.

.


.

257


.

"-"
.

. .
!

. .
%90
) ( . ) (

:


.
)
(
.

258

 .
.
.
.
.
.
) ( ) (
.
.
.
.
) (3 .

Take off your glasses and see _ by Jacob libormam

)1

The art of seeing _ by Aldous Huxley

Dr. Bates ; Learning to see

)2

)3

.
DVD ) (
.

259

 .

.

.
. .
.

:
. . 9 10 . 7 .

. .
.
. .
.

.

.

.

260

 :
" .
.
homocysteine
. B12 3
".

.


.

.

.

) (Degeneration .
.

.
.


.

.
.

261

 5 12 .
7 . .
) (
. .
15 100 4 )
( 10 )
RAL (.
. .
.

C-Reactive Protein
.
3 .
.

.

.

. .
.
.

262

. ..
.
...
.
...
.
....
.
.

"" .
.
.
.
.

263

 .

.
:
.
.
.
) ( .
.
.

:

56 30
3 2.5 .
. 3
)
(
.


. . 30
.
:
.
.
.

.
. .

264


. .

.
.
. .

.
. .
. .
.
.

.
.
.
.
. .
.

. .
.
.

.
.

265



.

.
.
.

. . 35 17
) AS(Ancylus
.
) . mg 500
( .
3 "
" " "
.

85
.
www.gerson.org
.

.
.

266

 .

:

.
. .

.
300 1
.
40 !
. .



. )
( .
.
85
.
)( ) (
.

.
. . 1
.

.

267

38 89 185 . 5 31

6

.
.
.
.


.
.
.

.
20 . 10 20
.
. . .
.
.
) - (
.
.

.

268

 : +

. 5
.
.

.
.
.
. .
} .
{.

.

.
.
. .

. 2 3 .

.
.

. .

269

. 59 168 76 . 85 73 .
3 . .
.
. . ) ( .
) ( . .
. .
220 . .


.
.
. .
. .
.
.
.
... . .
.
.


.
. .
) ( .
.
.

270

. 76 .
djd . .


.
.
.
D
.
- .
.
.
8 12 ) (3
.

271

. 52 89
. .
. .
:
.
.
) (...
) (... .
.
.

.
.
.
. .

272


.
. .
. .

273

. 80
. .
.
.
.

.
.

.
.
.
.
.
.
.
.

274

 .
. .

:
. .

.


) (
.
.
.
.
.

.
.
.
.


.
. .
.
.
.
.
.
) ( .

275

 ) (
.
. .
. .

.

:
.

. 20

.

.

.

.
.

.
. .

. 27 155 42 . mvp
. .
. ) ( .

276

 20
. .

!
.

.

.
.
.

.
)
(
.
.


.

.
.
.
.
.
.

277

 80 20
.
.

.
.
. .

. .

. 76 .
djd . .

.
.
.
D
.
- .
.
.
8 12 ) (3
.

278

. stage 4
.
.

.

.

.


.
.
.

.

http://www.PCRM.org/project
(1
(2

Gerson.org

279

17
)30( )33( .
. 6
.
10
. ) ( .
.
. )
( .
. . .

.
.
.

.
. .
.
10-6 .
.
:

280

.
.
.
: ..
: .
10-6 .

.
. clay pack .
.

) ( .
.
.
.
.

57 59 . 43
. 6

281

 . 85 .
. femara
.
.
. 6 75 .
) ( femara

. 75 85 90 .
6-4 .
.
) (
.
.
.
.
.
"" .

. . .
.

:

:
.
.

282

 . .
.
) (...
) (...( E (... .
.
) ( .
)
( .
.
.
. 50
.
.

:
Johira Afzali

. 20
. 4 .
.
.
.


.


.
.
.

283


. .
.
.
.
)(
.

) (
.
.
) (Gonzales .

.
.

2 4 8
.
.


.

.
) 6-4(
) ( .

284

 .
.
) 80 (

.

62 . . 15
. 3
. .
50 .
. .
.
.

.
.

.
.
.

.
.

.

.

285

 . .
.
.

. .

.
gerson.org .
80
.
.

.
.

.

.
.
.

.
.
. .

. .

.

286


.
.
80
.
.
.

. .

. .
5 ) (
. 2
.

. .
.
.
.

.
.
. .

.
.
.
. .

287

 . .
.

4 . . .
2 . 42 156 .
. .
. 4 5
. . . .

. .
) 80 ( .
.
.
. .
. . .
.
. .

14 .
. . 10
. .

288

 .
.
.

.

.
.
.
.

. . . .
.
.
. .
. .
. . .
. .

.
.
. .
.
) (Skype ) (ooVoo .
.

289

 3 15 45
. 110 750 200
.
2 4 78 163
74 67 .
70
. .

.

" " .

.
.
.
.

.
.
.
10 12 . 24 12
.
3 5 . .
.
.
. .
.
.
.
.

290

. 52 89
. .
. .

:
.
.
) (...
) (... .
.
.

.
.
.
. .

. 22
.
.

291


- 85
80 .
.
) (
.
.
)
( . .
.
.
.
.
.
.
. .

17
)30( )33( .
. 6
.
10
. ) ( .
.
. )

292

( .
. . .

.
.
.

.
. .
.
10-6 .
.
:

.
.
.
: ...
: .
10-6 .

293

 .
. clay pack .
.

) ( .
.
.
.
.

: -

.
.

.... .





.
.
.
.
.
.

294


.
. .
.
. .

.
3 15 45
. 110 750 200
.
2 4 78 163
74 67 .
70
.
.

" "
.

.
.
.
.

.
.
.
10 12 . 24 12
.
3 5 . .

295

 .
.
. .
.
.
.
.

57 59 .
43
. 6 . 85
.
. femara .
.
. 6 75 .
) ( femara

. 75 85 90 .
6-4 .

.
) (
.
.

296

 .
.
.
"" .

. . .
.

16 .
.

. .
. .
.

.
.
.

297

.
6 5 . .
.... .
.
2 3 . .
. . 2 20
-1 6 8 -2 . 40
20 .... . 84 .
. .
. ) 5
(. .
35 .... .

. .

.
.

.
.
3 6
.

.
5 7 .
.

298

 .
) ( .
.
. ) ( .
.
.

:
. . 2 . .
. . .....
. .
2
. .

:
) ( .
. b
.
. .
.
) (
.
.
. .
.
)(
. .
.

299

 .
.
.

. ) -(
. .
.

. 27 .
. .

.
.

.
) ( 85 .
15 .
.
.
.
) (
.
.
) (
.

300


.
)( .

.
: .
:
.
3 ) (
) 5 6( :
.
. ) 20 (49 ) ( 25
) (18 .

:

:
.
.
.
.

.
.
. :
.
:
. . .
)
( .

301

 .

. .
. .
. .
.
.
.
. .

. ) (
.
)
( . .
: .
.
.

:

29 5
.
.

!
.
.

302

 ) (

.
.
.

.
.


.

. 80 90
.
.

.

:

31 .
. spot .

303


. .
.
.

.
.


.

.

.
.

:

10 . 6. methotrexat 10 .
ld . 160 61
.

. .
.

304

 .
.
.
.

.

.
.
.
.

.
.
.
.
.
.

305

 .
.
.
Dr.
Bronners . .
paraben
.
.
.
.
.

:

:
.
.
. .
.
) (...
) (...( E (... .
.
) ( .
)
( .
.
.

306

 . 50
.
.

:

:
) (
.
.
.

) (
.
.
. .
.
.
. .
) (
.
.

.
E .
. .
E E . )
( 6 .

307

 )
(

.
) ( )
( )
(
. . .
.
.
) ( .
.
.
.
.
.
.
.
. .

5-10
.
.
.

308


. .
.

.
.
.
.
.

.
1 .
.

.
.

. .

:
.

309

 27 .
.

. .
. . .
.
.
.
.
. .
. .

.
. . .
. .
.

.


!
.

310

 .
.
.

.
.

.
. .

.
.
.

) (
"" .
. . .

.

.
.

.
.

.
.

311

. 50 3 .
. .
. 20 .

.
.
.
. .

.
.
.
.

:
.
. .
:

.
.
.

312

 .
.
) . (
.
.
.
.
) . (

.
.
.
" .
"
. .
100 -85
15 -0 .

.
.

. 9 ) (
ferritin 8 ng/ml
.

.
)
( .

313

 )(
.
.

.
.
. . .

.

: 2

43 171 77 2 . 7 . 40
.
40 7
.
: .
.

.
.
.
.
.
.
6 12 .
.

314

 .
.
.
.
.
.
. .

80- 85
.
.
. .

24 .
.

) ( .
.
.
.

315

.


.
. .
.

) ( .
.

.

.
.
.
.

. . 5


. .
.
. .
.

316

 :
:

.

.
.
.
.


.

.

. .
.
.

.
. 85 80
.
.... .
.
.
.
) . 15 10 (
.
.
-

) (non- Heme .
.

.
.
.
.

317

.
) (phytates .
.
.
.

.

. .
.

1 2 .

. .
.

.

.

.
.
. .
) (
.

318


.
) ( ... .

.
.

.
/ .
.

. .

.
.
.
.

319


.
. 5 15 .
) 3( .
. .
.
.

.

.



.
.

.

.

.
)
( .

.
.

320

. .
.
.
.

.
""
.

.

.

.
.
.
.
.
.

321

 13 . .
. .
.

. . .
.
.
.
.

.
.

. 27
: . .
.

322

. .
.
. . .
.
. 6 . . .
. . .

323

 .
.
. .
.
. ) (
.
.
.
.
.
.
.

324

. 4 2
.

.
.
.

.

.
.
. 4 2 " " :



.

.
.
.

. ...
. .

325

 . ...
.
.... .
. . ... 18
. ... ...

.

.


.

. 50 .
.
.
) ( .

.

.

.
.
. .
.
1/4 3/4
.
.
.
.
.
. .
.
.
.

326

. 50 3 .
. .
. 20 .

.
.
.
. .
.
.
.
.

327

38 3 .
.

. .
.






.

.
.

C .
.

.

328

.
SGOT=38, SGPT =78 . .
.
.
1500000 110000 .
.


.
.

.
.
.

.
.
. .
.
.
.

.
:
. ) -(
. .
.

329

 : )(

. 43 . .... . .

.
.

.

.

: 2

. . )123
175 ( . 2
.
. 15 10
.
) .
( 15 .
) (
. .
. .

.
.

330

 .
.
"" ""
.
.
: 80
.
.

.
.
.

. .
.
.
.
.
.
. )
( .

.

. .
.
.
.

331

 : . . )
(
.
.
.
.
.
:
. .
: .
.
.
" " .
.
. . .
.

: 2

. 2 . 500 1000 .
.
.
...

.
.
.
.
.

332


. .

.
.
.
.
) ( )
( .
85 80 .
20 -15 .
.
.
.
.
.
.
. .
.

alt 45 ast 30 1 . 25
175 50 . . .

.

.
. .

.

333

 .
6 . .
. .
.
.
.
.
.

. 50 .
. . .

. .
.
.

.
.
) 135 (136 .

334

20 . 75
.



.
75 . .

.
.
.
.


.
.
)
( .

.
) (milkthistle .

.
.

.

335

 .
.
.
.
. . .
.
.
12 24
.
.

.

.




. .
.

.
.
.
.
.
.
.
.

336

 .

.

. .
. 85 95
.
.
.
) (
.
.

.
...
.

.
.

. 4 .

. .
.

CAH . 600 . 700

... A,B,C .

337

 17 5 2 2 5
. OT, PT 50 60
255 .300 50 100 150 100
. .
. 65.5 51 .. .
34 . .

.
.
. .
. . 15
.
.
.
.

.
.
.

.
.
.
.
.
.
. .

: c

. c . .
. 4 . .
.

338

 .
.
.
. .
.

. .
!
.

:
.
. .
:

.
.
.
.
.
) . (
.
.
.
.
) . (

.
.

339

 .
" .
"
. .
100 -85
15 -0 .

.
.

:

:
.
.
.
.

.
.
. :
.
: .
. .
)
( .
.

. .
.
. .
. .
.
.
. .

340

 . ) (
.
)
( . .
: .
.
.

:

31 .
. spot .

. .
.
.

.
.


.
.

.
.

341

. 13 .
.
. . .
. .
. 12 .

. .
.
.
.
12 .
.
.
.
.

.
85 80 .

) ( .

.
.
.

342

44 2/5 .
.
.
.

.

.
.
.
.


.

.
.
.
.

... .
.
.
.
.

343


)( .
.
.
.

. .

.
.
.
. .
.
.
.

.

.


.
.
) ( .
.

.
.

344

.
. .

.
. . .

.

.

.
)
( .
) (
.
www.mcdugall.com
.
.

345

 .
.

. .
.
. . .
.
. 6 . . .
. . .

.


.
.
. .
.
. ) (
.
.
.
.
.
.
.

346

. 24 64 . . :

.
. 6
.
90-85 .
.
.
10 15
.
.
) ( .
.
.
.

347

12
.
.
.


. .

. .
.
.
:



) ( Epxom salt
.
6
8
10 .
.
6 8 .
.
:

.

348

) ( .
.
.

.

) ( .

4 10-9-7-5
ursuflour .
.

.
.
.
.
.

5
. ...
.

349

 . .
) 17( .

.
.
. .
. ) . (151

.
.
.
.

350

32 7 . .
12 .
12 .

.
.
.
.

.
.
.

.
.
.

:




..... .
.
2
. .

351

:
.
.
. .

.
.

. .
.
.
:

.
80-85 ) ( .

. .
. . .
.
.
. .
. .
.
.
. .
.
. .
.
.
.
.

352

:
.
.

.
.
. .
) (Phytates )
( . .


.
.
:
.
) (Phytates .
.
.
.
.

.
. .
:

. : .

353





. .
.
.

354


:



. "" .
.
.
.


.
.
. .
.
.
. . )
11 4 ( .
.
.

:

... .

355

1.
2. ) 8-7(

3.


) ( .

. .
.
.
.
.
. .
85
.
.
. .
.
.
.
.
.
.
.

356

 .
.
) ( .
. .
. .
.
. .
.

357


:
.
. .
-1
. .
) (

-2

-3

.
.
.
.
.
. .
.
. . .
. . .
.
. .
.
.
.

. 85 .
. .
.

358


:
:

.

.
.
.
.


.

.

. .
.
.

.
. 85 80
.
.... .
-

359

.
.
.
) . 15 10 (
.
.
) (non- Heme .
.

.
.
.
.
.
) (phytates .
.
.
.

.

:


:
.

. .



...
. .
.

.

360



: " "
.

.
85 :
)(
... . )
( . .


.
. . .
. .

:


.
.
.
80 85 .

361

 .

.
.
.
.

. .
.

1 2 .

. .

.

.

.

.
.
. .

362

 ) (
.

.
) ( ... .

.
.

.
/ .
.

. 59 168 76 . 85 73 .
3 . .
.
. . ) ( .
) ( . .
. .
220 . .


.
.
. .
. .
.

363

 .
.
... . .
.
.


.
. .
) ( .
.
.

:




.....
. .
2
. .
:
. .
. .

.
.

. .
.
.
:

.
80-85 ) ( .

364


. .
. . .
.
.
. .
. .
.
.
. .
.
. .
.
.
.
.

365

24 6 .
.
12 .
12 65
2 .
12 .
10 4 12 .
.
. 6
.
e, d ,a
.
.


.
.
:
.

366

 .
!


.

.
- ...
.
""
.
.

. ""
.
. "" .
.

. .
6 .
12 .
12 .
12
.
12 .

367

 12 .
. .
D .
. .
D .


.
.
.

) 12
(
.
.

368


:

. . .
. .

.
) ( .

.


. 90 95

. SuperMan SuperWoman !

.
.

.

369

 .
.
)
( .

)
! (.

:

.
48 Xiphoid process .

. . .

. .
. .
""
. . . .

.
.
.
. .

370


:
1
Optimal
. .
.
.
.
.
.

.
. .
. .
.
.
. .
.

.
.
.

...
.
.

.
.

.
.
. .

.

371

 .

.
.

. 24 24
. .
.
.
40 .
.
. .
.
. . ...

. .
. Kule (
( .
... .
.
.

.
) (
.
) (
. .
.

)
( .
.
.
. .
.

372

 . .
. !
!!

.

3 ) )...
. .

. .
.
. .

4 . . .
.
.
.
.
6 " " " " )
. ) (

.
. .

.
7-

.
DVD .
. 15

373



.
. .
90 . /
.
.
.
. . .
.
.
: . .
. . .

.
.

.


. )(
.
) (
. .
. .
.

) ( .
.

374

 .

.
.

.
.
. .
. .
.
.

.
) ( 50
.
.
50 ) betafaovil (
.
.

.
.
.
. .

.
. )
(

375

 . .
.

.

.

.

) 3 ( .
.
.

.


.
.
) (Farmers MKT
.
.
) (
.
.

.

.
. .

376


.
.
.
.
.
.
.
.

.
. .
.
.

( )

.
.
. !

377


.

.
.
.

.

.
. .

) ( .
. 80-85 .
12-24
.
.
.
.
) (... )
( ) (... .
" " " " " "
.
.
.
.

378

 .
.
.

17 153 63
6 3

.
. .
.
.
.

.
...
. .
.
. ) (
.
.

...

379

.
.
.
"" "" .
.
!
.
20
.
.
.
.

39
. .
. cm 180 75 65
. .
. ...
....
.
.
.
.
.
.
. . ...

380

. .
.
.

.
.
.
.
. .
.
. .

.
. . )
( .
.

.

:

.
.
.
.
lu 400
.
/

381


.
. .
.
.

. .
.
20 30 .
.
.

.
.
-2-30 .
. .
.

.
.
.
)
.
. ""
. ""
.

.

382


) (
.
.

7 .. ... 4 3..
.

.
.
. .
. .
.

.
.

.
.

.

.
)( .
.

383


:
1 chlorella2 : - - - - - - - - 6 - - 12 )( - - -
!) )
3 : ) ) -( )

) ( .
.
.
.

.
.

. .
12 ...
.

.
" " .
"
" .

.

384

 ) (British Medical Journal

D .
16000 D
22 .
.

!


... .

.
.
.
.
. .
.
. ) ( .
.
.

385

 41 162 104 3 6

100100
30


.

.
.

.
.
.
.
. .
.
.
. 12-24 .
.
. 2-5
.
.

. . . .

386

 .
. ) (
. . .
. .
. .
. .
. . .

.

.
. )
( ) ( .

.
.

.

.

.
. .

.
)
( ) (

387

 .
. .
" " .

.
.

.
.

100 ) ....
30 5 50
.

.
. .
.
.
. .
.
. 100 .
.

388

 .
.
) (
.
.
.
. .
.
: .

. .
Brazil nut
. ) (
) (Buck wheat ) (
. .
55 .
. .
. .
) ( . .
.

. : 70 4 .
5 24

" )
(
. ."

.
.

389



.
. ) (
.

.
.
.

.


.
.
.

.
.


.

) ( ...
) ( .
:
Nutri BIOTI forte
Foliron + Zinc
Spironolactone
Ecophanc

390

.
.
. .
.
.

. .
.
.
. .
.

.

145 168


7 25

.
.

.
.
.
.
!

391

 .
- -
.
.
.



.



.
1 . .

. : .

.
2 . . . . .
... .

. ) (
.
.
3 ... . .
.
.

392


. .
.
. .
.
4 : .
.
.
) ) ... . .
.
. . . . . .
. . .

.
.
. .
. . .
.
. 3-5 .
. ) ( .

.

393


.
. .
... .
. . .
. 2-3 . 3-4 . .
. . .
. . .
- . .
. . . . . .
.
. . . .
. .
:
. .
.
. ) ( .
. .
.
.

394

/
.
/
.
/ .
.
. .
)( .
.
5 .
.
.
. .
.
.
) (
.
:
.1 : )
( . .

.
.
.2 : .

. .
.
) ( .
.

395

 .
. .
.3 : . . .
. .
.
.4 :12
.
12 . 12
. 12
.
.5 : .
. . )(
.
.6 : .
) ( ) (Flax seed .
.
) ( .
.
:
. .
.
. . )!( .
.

.
.
- .

396

 1700 1987
.
.
2 .
1
.
.
.
.

15
7 .
. 63 190.


.
.

.

.
. .
. .
.
.

.

) (

.

397

 .
.
.

31 178 . 75 85
10 .

. )
(
) ( 10
.

.
) ( .

.
.
...
.

.
.
.
.

.

. 5 ) ( .
5 6
.

398

 5
.
.
... .
.

)
( .
.


!

.

.
. .
.
.
.
.
85

.

.

.. ..
. ..
. 10 2
. " .
. ..
) 15 .
( . "

399

 . ) (
3 . ..

. .
.
.
.
.

.
.
. ) (
.
4 ) (
) (
. .

:

.
DVD .
. 15



.

400


:
. . 9 10 . 7 .

. .
.
. .
.

.

.

.

401


:
" .
.
homocysteine
. B12 3
".

.


.

.

.

) (Degeneration .
.

.
.


.

.

402

 .
5 12 .
7 . .
) (
. .
15 100 4 )
( 10 )
RAL (.
. .
.

C-Reactive Protein
.
3 .
.

.

.

. .
.
.

403

 :
.

.





.

:



.
.
1996 .
90 .
.

.


) ( .
) (FDA

. .
:

404

 .
.

.
.
50 .
.
.

.

.

. .

!

405


:
.. ...
...
...

..

.
. ) (
.
.
.
.
.
.
:

Resume
:






)1357(
) (1982 )(1983
) UTMB (

406

 )(1993
) (UCI 14
.

.
.
( How to heal your colitis despite what your doctor says
(
.
1990 .
.
7 8 .
.
) PCRM (Physicians Committee for Responsible Medicine
) 1995 ( . 4000
120000 ... ) .
(
) NHA (National Health Association
.
.
Gerson Institute .
) (Certificate Our Place International
.
20
... .

.
Dave Klein )
( .
...

407



.
.

www.ZarinAzar.com
:
DrZarinAzar.Blogfa.com

411